These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2392805)

  • 1. Development of a physiologically based pharmacokinetic model for risk assessment with 1,4-dioxane.
    Reitz RH; McCroskey PS; Park CN; Andersen ME; Gargas ML
    Toxicol Appl Pharmacol; 1990 Aug; 105(1):37-54. PubMed ID: 2392805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer risk assessment for dioxane based upon a physiologically-based pharmacokinetic approach.
    Leung HW; Paustenbach DJ
    Toxicol Lett; 1990 Apr; 51(2):147-62. PubMed ID: 2158678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologically based pharmacokinetic modeling of 1,4-Dioxane in rats, mice, and humans.
    Sweeney LM; Thrall KD; Poet TS; Corley RA; Weber TJ; Locey BJ; Clarkson J; Sager S; Gargas ML
    Toxicol Sci; 2008 Jan; 101(1):32-50. PubMed ID: 17897969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated evaluation of the carcinogenic potential of 1,4-dioxane.
    Stickney JA; Sager SL; Clarkson JR; Smith LA; Locey BJ; Bock MJ; Hartung R; Olp SF
    Regul Toxicol Pharmacol; 2003 Oct; 38(2):183-95. PubMed ID: 14550759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent fate of 1,4-dioxane in rats.
    Young JD; Braun WH; Gehring PJ
    J Toxicol Environ Health; 1978; 4(5-6):709-26. PubMed ID: 731724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dose-dependent fate of 1,4-dioxane in rats.
    Young JD; Braun WH; Gehring PJ
    J Environ Pathol Toxicol; 1978; 2(2):263-82. PubMed ID: 739213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modeling.
    Reitz RH; Mendrala AL; Corley RA; Quast JF; Gargas ML; Andersen ME; Staats DA; Conolly RB
    Toxicol Appl Pharmacol; 1990 Sep; 105(3):443-59. PubMed ID: 2237918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinogenicity studies of 1,4-dioxane administered in drinking-water to rats and mice for 2 years.
    Kano H; Umeda Y; Kasai T; Sasaki T; Matsumoto M; Yamazaki K; Nagano K; Arito H; Fukushima S
    Food Chem Toxicol; 2009 Nov; 47(11):2776-84. PubMed ID: 19703511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
    Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of action analysis for liver tumors from oral 1,4-dioxane exposures and evidence-based dose response assessment.
    Dourson M; Reichard J; Nance P; Burleigh-Flayer H; Parker A; Vincent M; McConnell EE
    Regul Toxicol Pharmacol; 2014 Apr; 68(3):387-401. PubMed ID: 24491968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year inhalation study of carcinogenicity and chronic toxicity of 1,4-dioxane in male rats.
    Kasai T; Kano H; Umeda Y; Sasaki T; Ikawa N; Nishizawa T; Nagano K; Arito H; Nagashima H; Fukushima S
    Inhal Toxicol; 2009 Sep; 21(11):889-97. PubMed ID: 19681729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 90-day drinking water study in mice to characterize early events in the cancer mode of action of 1,4-dioxane.
    Lafranconi M; Budinsky R; Corey L; Klapacz J; Crissman J; LeBaron M; Golden R; Pleus R
    Regul Toxicol Pharmacol; 2021 Feb; 119():104819. PubMed ID: 33189748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and toxicokinetics of 1,4-dioxane in humans after inhalational exposure at rest and under physical stress.
    Göen T; von Helden F; Eckert E; Knecht U; Drexler H; Walter D
    Arch Toxicol; 2016 Jun; 90(6):1315-24. PubMed ID: 26223317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetic modeling with methylchloroform: implications for interspecies, high dose/low dose, and dose route extrapolations.
    Reitz RH; McDougal JN; Himmelstein MW; Nolan RJ; Schumann AM
    Toxicol Appl Pharmacol; 1988 Sep; 95(2):185-99. PubMed ID: 3420611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
    Andersen ME; Clewell HJ; Gargas ML; MacNaughton MG; Reitz RH; Nolan RJ; McKenna MJ
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):14-27. PubMed ID: 1900959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is 1,4-dioxane a genotoxic carcinogen?
    Kitchin KT; Brown JL
    Cancer Lett; 1990 Aug; 53(1):67-71. PubMed ID: 2397485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,4-Dioxane and beta-hydroxyethoxyacetic acid excretion in urine of humans exposed to dioxane vapors.
    Young JD; Braun WH; Gehring PJ; Horvath BS; Daniel RL
    Toxicol Appl Pharmacol; 1976 Dec; 38(3):643-6. PubMed ID: 1014018
    [No Abstract]   [Full Text] [Related]  

  • 18. Oncogenic activity of an m-dioxane derivatives: 2,6-dimethyl-m-dioxan-4-ol acetate (dimethoxane).
    Hoch-Ligeti C; Argus MF; Arcos JC
    J Natl Cancer Inst; 1974 Sep; 53(3):791-4. PubMed ID: 4370242
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,4-Dioxane.
    IARC Monogr Eval Carcinog Risk Chem Man; 1976; 11():247-56. PubMed ID: 791822
    [No Abstract]   [Full Text] [Related]  

  • 20. Update: Mode of action (MOA) for liver tumors induced by oral exposure to 1,4-dioxane.
    Dourson ML; Higginbotham J; Crum J; Burleigh-Flayer H; Nance P; Forsberg ND; Lafranconi M; Reichard J
    Regul Toxicol Pharmacol; 2017 Aug; 88():45-55. PubMed ID: 28366800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.